Prospective payment.Concord, MA, International Health Services, Lt., 1983.
2.
RAPPR.P., GRANTK., PIECOROJ.J.Guidelines for the administration of commonly used intravenous drugs: an update. Drug Intell Clin Pharm1976; 10: 206–15.
3.
DUMAR.J., WANIERJ.F., DALTONH.P.Septicemia from intravenous infusion. N Engl J Med1971; 284: 251–60.
4.
MCALISTERJ.C., BUCHANANE.C., SKOLAUTM.W.A comparison of the safety and efficiency of three intermittent intravenous therapy systems—the minibottle, and the minibag and the in-line burette. Am J Hosp Pharm1974; 31: 961–7.
5.
PAXINASJ., HAMNIELR.J., FRITZW.L.Contamination rates and cost associated with the use of four intermittent intravenous infusion systems. Am J Hosp Pharm1979; 36: 1497–1503.
6.
MEDEIRASG., HEBBARDF.J.Economic justification for purchasing commercially available drugs in intravenous piggyback bottles. Presented at the 1979 Midyear Meeting of the American Society of Hospital Pharmacists, Las Vegas, NV.
7.
KILSDONKG.F., PARKERP.F., PIECOROJ.J.Evaluation of an innovative system for intermittent intravenous drug administration, Infusion1982; (July/Aug): 102–8.